Science and technological development have advanced rapidly, incorporating new discoveries and paradigm shifts into curative and preventive medical care. These advances include bio-drugs, robotics, nanodevices, therapeutic vaccines, individualized treatments, among others. Genomics is a relevant area of the present and future of medicine. It is responsible for many of the abovementioned advances. Genomics is aimed at a predictive, personalized and preventive medicine. However, as in many other medical fields, access to genomics is unequal and determined by the patients' socioeconomic background. This is a challenge for the current health systems, in terms of improving the availability of these advances to the entire population.
Over the past decades, there has been increasing interest in the study of genetic predispositions to complex diseases. This interest has materialized in a large amount of epidemiological publications on associations between gene and disease. However, the magnitude of the association between a given genotype and a given condition has not always been determined.
Given the above, it is necessary to identify the true genetic associations between the presence of a complex disease and the underlying genotype. In this context, it is necessary to implement sufficiently strong computer networks to achieve good connectivity and interoperability of clinical, laboratory and public health systems. In addition, the storage and use of genetic and non-genetic information for research and development must consider bioethical aspects such as privacy, protection of genomic data and informed consent.
